arrow
J

Jérôme Ambroise

Institute of Experimental and Clinical Research
H指数:26
被引数:2,412

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impaired IgA mucosal immunity following lung transplantation: a potential trigger for bronchiolitis obliterans syndrome
2025-11-010
PRE
Deleting ACC1 in platelets alters phospholipidome and reduces platelet activation and thrombosis in mice

删除血小板中的ACC1会改变磷脂组并降低小鼠的血小板活化和血栓形成

2025-07-050
OAAI
Unique transcriptomic responses of rat and human alveolar macrophages in an in vitro model of overload with TiO2 and carbon black

大鼠和人肺泡巨噬细胞在TiO2和碳黑过载的体外模型中的独特转录组反应

2025-04-250
OA
Response to neoadjuvant chemotherapy in early breast cancers is associated with epithelial-mesenchymal transition and tumor-infiltrating lymphocytes

早期乳腺癌对新辅助化疗的反应与上皮间质转化和肿瘤浸润淋巴细胞有关

2025-02-060
OAAI
PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma

PPARα介导的脂质代谢重编程支持头颈部鳞状细胞癌中抗EGFR疗法的耐药性。

2025-02-010
OA
Acid-exposed and hypoxic cancer cells do not overlap but are interdependent for unsaturated fatty acid resources
2024-11-210
OAAI
Tumor-agnostic plasma assay for circulating tumor DNA detects minimal residual disease and predicts outcome in locally advanced squamous cell carcinoma of the head and neck

循环肿瘤DNA的肿瘤不可知血浆测定可检测微小残留疾病并预测头颈部局部晚期鳞状细胞癌的预后

2023-12-0115
OA
Mucosal immune alterations at the early onset of tissue destruction in chronic obstructive pulmonary disease
2023-10-176
OAAI
Minimal residual disease (MRD) diagnosed by a plasma tumor-agnostic circulating tumor DNA (ctDNA) assay after curative therapy in locally advanced (LA) squamous cell carcinoma of the head and neck (SCCHN) predicts disease relapse and survival
2023-10-010
OA
Disruption of GCN2 Pathway Aggravates Vascular and Parenchymal Remodeling during Pulmonary Fibrosis
2023-03-018
OA